ID | 蛋白ID | Accession | GN:Name | DE:Name | GeneID |
124152 | EPMA_BUCA5 | B8D8E5 | epmA {ECO:0000255|HAMAP-Rule:MF_00174} | Elongation factor P--(R)-beta-lysine ligase {ECO:0000255|HAMAP-Rule:MF_00174}; EF-P--(R)-beta-lysine ligase {ECO:0000255|HAMAP-Rule:MF_00174}; 6.3.1.- {ECO:0000255|HAMAP-Rule:MF_00174}; EF-P post-translational modification enzyme A {ECO:0000255|HAMAP-Rule:MF_00174}; EF-P-lysine lysyltransferase {ECO:0000255|HAMAP-Rule:MF_00174} | 0 |
124151 | EPMA_BAUCH | Q1LSP8 | epmA {ECO:0000255|HAMAP-Rule:MF_00174} | Elongation factor P--(R)-beta-lysine ligase {ECO:0000255|HAMAP-Rule:MF_00174}; EF-P--(R)-beta-lysine ligase {ECO:0000255|HAMAP-Rule:MF_00174}; 6.3.1.- {ECO:0000255|HAMAP-Rule:MF_00174}; EF-P post-translational modification enzyme A {ECO:0000255|HAMAP-Rule:MF_00174}; EF-P-lysine lysyltransferase {ECO:0000255|HAMAP-Rule:MF_00174} | 0 |
124150 | EPMA_AVIPA | Q9ZIY0 | epmA {ECO:0000255|HAMAP-Rule:MF_00174} | Elongation factor P--(R)-beta-lysine ligase {ECO:0000255|HAMAP-Rule:MF_00174}; EF-P--(R)-beta-lysine ligase {ECO:0000255|HAMAP-Rule:MF_00174}; 6.3.1.- {ECO:0000255|HAMAP-Rule:MF_00174}; EF-P post-translational modification enzyme A {ECO:0000255|HAMAP-Rule:MF_00174}; EF-P-lysine lysyltransferase {ECO:0000255|HAMAP-Rule:MF_00174} | 0 |
124149 | EPMA_ACTSZ | A6VQ84 | epmA {ECO:0000255|HAMAP-Rule:MF_00174} | Elongation factor P--(R)-beta-lysine ligase {ECO:0000255|HAMAP-Rule:MF_00174}; EF-P--(R)-beta-lysine ligase {ECO:0000255|HAMAP-Rule:MF_00174}; 6.3.1.- {ECO:0000255|HAMAP-Rule:MF_00174}; EF-P post-translational modification enzyme A {ECO:0000255|HAMAP-Rule:MF_00174}; EF-P-lysine lysyltransferase {ECO:0000255|HAMAP-Rule:MF_00174} | 0 |
124148 | EPMAH_AQUAE | O66963 | genX | Elongation factor P--(R)-beta-lysine ligase homolog; EF-P--(R)-beta-lysine ligase homolog | 0 |
124147 | EPM2A_RAT | F1LPW7; Q91XQ2 | Epm2a | Laforin; 3.1.3.- {ECO:0000250|UniProtKB:Q9WUA5}; 3.1.3.16; 3.1.3.48 {ECO:0000250|UniProtKB:O95278}; Glucan phosphatase; Lafora PTPase; LAFPTPase | 114005 |
124146 | EPM2A_MOUSE | G5E8E2; Q8BY80; Q9WUA5 | Epm2a | Laforin {ECO:0000303|PubMed:16971387}; 3.1.3.- {ECO:0000269|PubMed:16971387, ECO:0000269|PubMed:18040046, ECO:0000269|PubMed:24430976}; 3.1.3.16; 3.1.3.48 {ECO:0000269|PubMed:16971387}; Glucan phosphatase; Lafora PTPase; LAFPTPase | 13853 |
124145 | EPM2A_HUMAN | B3KMU5; B4DRZ2; O95278; O95483; Q5T3F5; Q6IS15; Q8IU96; Q8IX24; Q8IX25 | EPM2A | Laforin {ECO:0000303|PubMed:11001928}; 3.1.3.- {ECO:0000269|PubMed:16901901, ECO:0000269|PubMed:23922729, ECO:0000269|PubMed:25538239, ECO:0000269|PubMed:25544560, ECO:0000269|PubMed:26231210}; 3.1.3.16 {ECO:0000305|PubMed:11001928}; 3.1.3.48 {ECO:0000269|PubMed:11001928, ECO:0000269|PubMed:11220751}; Glucan phosphatase {ECO:0000303|PubMed:16901901, ECO:0000303|PubMed:25538239}; Glycogen phosphatase {ECO:0000303|PubMed:25538239, ECO:0000303|PubMed:25544560}; Lafora PTPase; LAFPTPase {ECO:0000303|PubMed:11175283} | 7957 |
124144 | EPM2A_CANLF | Q1M199 | EPM2A | Laforin; 3.1.3.- {ECO:0000250|UniProtKB:Q9WUA5}; 3.1.3.16; 3.1.3.48 {ECO:0000250|UniProtKB:O95278}; Glucan phosphatase; Lafora PTPase; LAFPTPase | 0 |
124143 | EPL1_YEAST | D6VTK6; P43572 | EPL1 | Enhancer of polycomb-like protein 1 | 850520 |
124142 | EPL1_YARLI | Q6CEV5 | EPL1 | Enhancer of polycomb-like protein 1 | 2907028 |
124141 | EPL1_SCHPO | Q9UU94 | epl1 | Enhancer of polycomb-like protein 1 | 2539428 |
124140 | EPL1_NEUCR | Q7S747 | epl-1 | Enhancer of polycomb-like protein 1 | 3876740 |
124139 | EPL1_KLULA | Q6CIN8 | EPL1 | Enhancer of polycomb-like protein 1 | 2895178 |
124138 | EPL1_GIBZE | A0A098DNR4; A0A0E0S989; I1RTA4; Q4I5V3; V6RI92 | EPL1 | Enhancer of polycomb-like protein 1 | 23554483 |
124137 | EPL1_EMENI | C8V0V0; Q5AYR3 | epl1 | Enhancer of polycomb-like protein 1 | 2870687 |
124136 | EPL1_DEBHA | Q6BNX0 | EPL1 | Enhancer of polycomb-like protein 1 | 2902479 |
124135 | EPL1_CRYNJ | P0CN58; Q55HM9; Q5K767 | EPL1 | Enhancer of polycomb-like protein 1 | 3255463 |
124134 | EPL1_CRYNB | P0CN59; Q55HM9; Q5K767 | EPL1 | Enhancer of polycomb-like protein 1 | 4939700 |
124133 | EPL1_CANGA | Q6FLZ0 | EPL1 | Enhancer of polycomb-like protein 1 | 2889983 |
124132 | EPL1_CANAL | A0A1D8PRL5; Q5AAG1 | EPL1 | Enhancer of polycomb-like protein 1 | 3639732 |
124131 | EPL1_ASPFU | Q4WDF1 | epl1 | Enhancer of polycomb-like protein 1 | 3505203 |
124130 | EPL1_ASHGO | Q752Q3 | EPL1 | Enhancer of polycomb-like protein 1 | 4622346 |
124129 | EPI_CERS4 | Q3IZP4 | epi {ECO:0000303|PubMed:18819910} | Ethylmalonyl-CoA/methylmalonyl-CoA epimerase {ECO:0000303|PubMed:18819910}; 5.1.99.- {ECO:0000269|PubMed:18819910}; 5.1.99.1 {ECO:0000269|PubMed:18819910} | 67447565 |
124128 | EPIZ_STAEP | P30193 | epiY' | Uncharacterized protein in epiA 5'region | 0 |
124127 | EPIY_STAEP | P30194 | epiY | Uncharacterized 16.7 kDa protein in epiA 5'region | 0 |
124126 | EPIQ_STAEP | P30198 | epiQ | Putative epidermin response regulator | 0 |
124125 | EPIP_STAEP | P30199 | epiP | Epidermin leader peptide-processing serine protease EpiP; 3.4.21.- | 0 |
124124 | EPIPL_MOUSE | Q8R0W0 | Eppk1 {ECO:0000312|MGI:MGI:2386306} | Epiplakin {ECO:0000303|PubMed:12791695} | 223650 |
124123 | EPIPL_HUMAN | A0A087X1U6; P58107; Q76E58; Q9NSU9 | EPPK1 {ECO:0000303|PubMed:14708632, ECO:0000312|HGNC:HGNC:15577} | Epiplakin {ECO:0000303|PubMed:11278896}; 450 kDa epidermal antigen | 83481 |
124122 | EPIP1_EPING | P83340 | | Major allergen Epi p 1; 3.4.21.-; Allergen EpI n I4625*; Epi p 1 | 0 |
124121 | EPID_STAEP | P30197 | epiD | Epidermin decarboxylase; 4.1.1.-; Epidermin-modifying enzyme EpiD | 0 |
124120 | EPIC_STAEP | P30196 | epiC | Epidermin biosynthesis protein EpiC | 0 |
124119 | EPIC4_PHYIT | D0MSS2 | EPIC4 {ECO:0000303|PubMed:17085509} | Cystatin-like cysteine protease inhibitor EPIC4 {ECO:0000303|PubMed:17085509}; Extracellular protease inhibitor with cystatin-like domain protein 4 {ECO:0000303|PubMed:17085509}; Secreted effector EPIC4 {ECO:0000303|PubMed:17085509} | 9476578 |
124118 | EPIC4_PHYIN | A1L019 | EPIC4 {ECO:0000303|PubMed:17085509} | Cystatin-like cysteine protease inhibitor EPIC4 {ECO:0000303|PubMed:17085509}; Extracellular protease inhibitor with cystatin-like domain protein 4 {ECO:0000303|PubMed:17085509}; Secreted effector EPIC4 {ECO:0000303|PubMed:17085509} | 0 |
124117 | EPIC3_PHYIT | D0NP95 | EPIC3 {ECO:0000303|PubMed:17085509} | Cystatin-like cysteine protease inhibitor EPIC3 {ECO:0000303|PubMed:17085509}; Extracellular protease inhibitor with cystatin-like domain protein 3 {ECO:0000303|PubMed:17085509}; Secreted effector EPIC3 {ECO:0000303|PubMed:17085509} | 9467999 |
124116 | EPIC3_PHYIN | A1L018 | EPIC3 {ECO:0000303|PubMed:17085509} | Cystatin-like cysteine protease inhibitor EPIC3 {ECO:0000303|PubMed:17085509}; Extracellular protease inhibitor with cystatin-like domain protein 3 {ECO:0000303|PubMed:17085509}; Secreted effector EPIC3 {ECO:0000303|PubMed:17085509} | 0 |
124115 | EPIC1_PHYIT | D0NBV1 | EPIC1 {ECO:0000303|PubMed:17085509} | Cystatin-like cysteine protease inhibitor EPIC1 {ECO:0000303|PubMed:17085509}; Extracellular protease inhibitor with cystatin-like domain protein 1 {ECO:0000303|PubMed:17085509}; Secreted effector EPIC1 {ECO:0000303|PubMed:17085509} | 9470507 |
124114 | EPIC1_PHYIN | A1L015 | EPIC1 {ECO:0000303|PubMed:17085509} | Cystatin-like cysteine protease inhibitor EPIC1 {ECO:0000303|PubMed:17085509}; Extracellular protease inhibitor with cystatin-like domain protein 1 {ECO:0000303|PubMed:17085509}; Secreted effector EPIC1 {ECO:0000303|PubMed:17085509} | 0 |
124113 | EPIB_STAEP | P30195 | epiB | Epidermin biosynthesis protein EpiB | 0 |
124112 | EPI2B_PHYIT | D0NBV3 | EPIC2B {ECO:0000303|PubMed:17085509} | Cystatin-like cysteine protease inhibitor EPIC2B {ECO:0000303|PubMed:17085509}; Extracellular protease inhibitor with cystatin-like domain protein 2B {ECO:0000303|PubMed:17085509}; Secreted effector EPIC2B {ECO:0000303|PubMed:17085509} | 9470509 |
124111 | EPI2B_PHYIN | A1L017 | EPIC2B {ECO:0000303|PubMed:17085509} | Cystatin-like cysteine protease inhibitor EPIC2B {ECO:0000303|PubMed:17085509}; Extracellular protease inhibitor with cystatin-like domain protein 2B {ECO:0000303|PubMed:17085509}; Secreted effector EPIC2B {ECO:0000303|PubMed:17085509} | 0 |
124110 | EPI2A_PHYIT | A1L016; D0NBV4 | EPIC2A {ECO:0000303|PubMed:17085509} | Cystatin-like cysteine protease inhibitor EPIC2A {ECO:0000303|PubMed:17085509}; Extracellular protease inhibitor with cystatin-like domain protein 2A {ECO:0000303|PubMed:17085509}; Secreted effector EPIC2A {ECO:0000303|PubMed:17085509} | 9470510 |
124109 | EPI1_PHYIT | D0MVC9 | EPI1 {ECO:0000303|PubMed:15096512} | Extracellular protease inhibitor 1 {ECO:0000303|PubMed:15096512}; Secreted effector EPI1 {ECO:0000303|PubMed:15096512} | 9468739 |
124108 | EPI1_PHYIN | Q6PQH2 | EPI1 {ECO:0000303|PubMed:15096512} | Extracellular protease inhibitor 1 {ECO:0000303|PubMed:15096512}; Secreted effector EPI1 {ECO:0000303|PubMed:15096512} | 0 |
124107 | EPI1_CAEEL | Q21313 | epi-1 | Laminin-like protein epi-1 | 177956 |
124106 | EPI10_PHYIT | D0NJ41 | EPI10 {ECO:0000303|PubMed:15096512} | Extracellular protease inhibitor 10 {ECO:0000303|PubMed:15096512}; Secreted effector EPI10 {ECO:0000303|PubMed:15096512} | 9473138 |
124105 | EPI10_PHYIN | Q6PQG3 | EPI10 {ECO:0000303|PubMed:15096512} | Extracellular protease inhibitor 10 {ECO:0000303|PubMed:15096512}; Secreted effector EPI10 {ECO:0000303|PubMed:15096512} | 0 |
124104 | EPHX4_MOUSE | F8VQ47; Q6IE26 | Ephx4 | Epoxide hydrolase 4; 3.3.-.-; Abhydrolase domain-containing protein 7; Epoxide hydrolase-related protein | 384214 |
124103 | EPHX4_HUMAN | Q8IUS5; Q8NCC6 | EPHX4 | Epoxide hydrolase 4; 3.3.-.-; Abhydrolase domain-containing protein 7; Epoxide hydrolase-related protein | 253152 |